Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plop appears to be an active digital health company centered on a consumer-facing mobile application for gut health tracking. Its product helps users log bowel movements, identify digestive triggers, analyze stool patterns, and share reports with clinicians or other healthcare providers. Based on available public information, the company is not a drug developer, biotech therapeutics company, or traditional pharma business; instead it operates in healthcare software and self-management tools for digestive wellness. No evidence was found of a therapeutic drug pipeline, clinical-stage assets, or proprietary biologic or small-molecule programs. The business is best characterized as a commercial-stage mobile health platform focused on gastrointestinal symptom tracking and patient-generated health data.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plop.